Literature DB >> 1348583

Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia.

L Friedman1, J A Jesberger, H Y Meltzer.   

Abstract

The effect of typical neuroleptic drugs or clozapine on smooth pursuit eye movements was tested in 13 patients with schizophrenia or schizoaffective disorder with a repeated measures design. Nineteen normal control subjects were also studied. Compared with controls, patients in the unmedicated state had low smooth pursuit gain, had a higher rate of corrective catch-up saccades, and tended to spend less time engaged in the tracking task. The patients did not significantly differ from controls on catch-up saccade amplitude, square wave jerk rate, or anticipatory saccade rate. Medication with clozapine, but not typical neuroleptics, was associated with an increase in median catch-up saccade amplitude. Number of days on clozapine and clozapine dose both correlated significantly with a worsening of oculomotor performance. No effect of medication with typical neuroleptics was found, although there was some evidence suggesting that such an affect may occur after more prolonged treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348583     DOI: 10.1016/0165-1781(92)90015-u

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Vergence eye movements in patients with schizophrenia.

Authors:  Mark S Bolding; Adrienne C Lahti; David White; Claire Moore; Demet Gurler; Timothy J Gawne; Paul D Gamlin
Journal:  Vision Res       Date:  2014-08-01       Impact factor: 1.886

2.  Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia.

Authors:  Rebekka Lencer; Andreas Sprenger; Margret S H Harris; James L Reilly; Matcheri S Keshavan; John A Sweeney
Journal:  Arch Gen Psychiatry       Date:  2008-10

Review 3.  Pharmacological treatment effects on eye movement control.

Authors:  James L Reilly; Rebekka Lencer; Jeffrey R Bishop; Sarah Keedy; John A Sweeney
Journal:  Brain Cogn       Date:  2008-12       Impact factor: 2.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.